Trial Profile
A 24 week randomized, double-blind, double-dummy, multicenter study to compare the efficacy of formulation X and Avandia (8mg OD) in subjects with type 2 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Aug 2023
Price :
$35
*
At a glance
- Drugs Rosiglitazone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 01 Aug 2007 New trial record.